IRIS
DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.403
EU - Europa 7.910
AS - Asia 6.977
Continente sconosciuto - Info sul continente non disponibili 1.000
SA - Sud America 763
AF - Africa 111
OC - Oceania 12
Totale 28.176
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.182
SG - Singapore 2.782
CN - Cina 1.992
RU - Federazione Russa 1.450
IT - Italia 1.373
IE - Irlanda 998
UA - Ucraina 996
GB - Regno Unito 873
SE - Svezia 722
TR - Turchia 714
BR - Brasile 580
VN - Vietnam 563
FR - Francia 496
DE - Germania 463
IN - India 322
FI - Finlandia 213
HK - Hong Kong 141
CA - Canada 110
BD - Bangladesh 97
MX - Messico 70
AR - Argentina 62
JP - Giappone 62
ES - Italia 59
IQ - Iraq 57
PL - Polonia 50
NL - Olanda 47
AT - Austria 38
ZA - Sudafrica 37
CO - Colombia 31
KR - Corea 31
EC - Ecuador 28
CH - Svizzera 25
VE - Venezuela 25
ID - Indonesia 24
CZ - Repubblica Ceca 23
SA - Arabia Saudita 20
BE - Belgio 19
PK - Pakistan 19
MA - Marocco 18
MY - Malesia 18
PH - Filippine 18
LT - Lituania 15
IL - Israele 14
LB - Libano 13
UZ - Uzbekistan 12
CL - Cile 11
EG - Egitto 11
EU - Europa 11
IR - Iran 11
KE - Kenya 11
TH - Thailandia 11
JM - Giamaica 10
JO - Giordania 10
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
PE - Perù 8
TN - Tunisia 8
AU - Australia 7
RS - Serbia 7
GR - Grecia 6
NP - Nepal 6
UY - Uruguay 6
OM - Oman 5
PT - Portogallo 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
RO - Romania 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
DO - Repubblica Dominicana 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PA - Panama 3
SV - El Salvador 3
TW - Taiwan 3
BH - Bahrain 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
Totale 27.166
Salva come PNG Salva come JPEG
Città #
Singapore 1.983
Chandler 1.323
San Jose 1.303
Jacksonville 1.202
Dublin 993
Ashburn 677
Dearborn 642
Southend 574
Dallas 547
Beijing 511
Princeton 475
Council Bluffs 403
Izmir 376
Nanjing 344
Los Angeles 286
Santa Clara 208
Chieti 200
Wilmington 184
Cambridge 183
Ho Chi Minh City 179
Tongling 151
The Dalles 132
New York 130
Hong Kong 127
Nanchang 125
Altamura 120
Buffalo 119
Ann Arbor 113
Moscow 113
Hanoi 112
Boardman 90
Munich 87
Rome 80
Kunming 71
Orem 65
São Paulo 65
Pescara 64
Shenyang 60
Hebei 59
Redondo Beach 58
Phoenix 52
Dong Ket 49
Milan 47
Tokyo 47
Jiaxing 45
Washington 44
Woodbridge 42
Chicago 40
Tianjin 40
Brooklyn 39
Chennai 38
Warsaw 38
Hefei 37
Montreal 36
Norwalk 36
Columbus 34
Houston 34
Vienna 32
Atlanta 31
Boston 30
Da Nang 29
Frankfurt am Main 29
Stockholm 29
Changsha 28
Toronto 28
Amsterdam 27
Nuremberg 27
Pune 24
Hangzhou 23
Johannesburg 22
Poplar 22
Memphis 21
Mumbai 21
San Francisco 21
Seattle 21
Seoul 21
Augusta 20
Baghdad 20
Civitanova Marche 20
Denver 20
Grevenbroich 20
Jinan 20
Mexico City 20
Haiphong 19
Rio de Janeiro 19
San Mateo 19
Brussels 18
London 18
Guangzhou 17
Orange 17
Zhengzhou 17
Ankara 16
Düsseldorf 16
Shanghai 16
Ancona 15
Dhaka 15
Helsinki 15
Turku 15
Brno 14
Kocaeli 14
Totale 16.138
Salva come PNG Salva come JPEG
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 861
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 222
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 205
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 197
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 192
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 189
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 187
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 176
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 174
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 172
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 168
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 167
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 165
Colonic adenoma-associated Escherichia coli express specific phenotypes 162
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 159
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 158
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 153
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 152
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 151
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 151
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 148
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 146
In vitro microbiology studies on a new peritoneal dialysis connector 145
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 144
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 144
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 143
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 141
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 138
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 137
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 137
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 137
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 137
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 137
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 136
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 136
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 135
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 135
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 135
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 134
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 133
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 133
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 132
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 131
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 130
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 129
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 129
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 129
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 129
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 129
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 129
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 128
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 128
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 128
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 127
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 127
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 127
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 127
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 127
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 126
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 126
null 125
A case ofpharyngitis caused by Streptococcus pneumoniae. 125
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. 124
Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview 124
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 123
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 123
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 123
Normal breathing releases SARS-CoV-2 into the air 123
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 122
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 122
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 122
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 121
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 121
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 121
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 121
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 120
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 120
Attività in vitro di roxitromicina in confronto con eritromicina verso Actinobacillus actinomycetemcomitans. 119
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 119
Effetti dell’antibiotico-resistenza di H. pylori sulle terapie eradicanti. 119
Hafnia alvei from the farm to the delivery room 119
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 118
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 118
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 118
Spiral and coccoid forms of H. pylori in gastric mucosa biopsies: an electron microscopy study. 118
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 117
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 117
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 117
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 117
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 116
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 116
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 116
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 116
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 116
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 116
Caratterizzazione fenotipica e genotipica della formazione di biofilm da parte di Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 116
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 116
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 115
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 115
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 115
Totale 14.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.183 0 0 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.743 248 614 464 115 88 146 136 159 472 184 441 676
2025/20268.769 590 344 874 885 848 429 1.518 619 1.417 688 424 133
2026/2027846 299 442 105 0 0 0 0 0 0 0 0 0
Totale 28.176